Sofwave to Participate in the Jefferies Virtual Private MedTech Summit

SAN CLEMENTE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Private MedTech Summit, to be held virtually from October 2-3, 2024.

Jefferies Virtual Private MedTech Summit

Format: Corporate update and one-on-one investor meetings

Presentation Date: Wednesday, October 2, 2024

Presentation Time: 11:30 a.m. ET

Webcast: Click Here

About Sofwave Medical
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), lifting lax skin in the arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: Info@sofwave.com

Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
britchie@lifesciadvisors.com